drugset / Trial / NCT01124045

Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery

NCT01124045

Phase 3 Completed 80 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study was to compare the safety and efficacy of Durezol™ compared to Pred Forte™ for the treatment of inflammation following cataract surgery in a pediatric population 0 to 3 years of age.

Timeline

Start
2010-08
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Difluprednate Small molecule 0.05 % Topical
Comparator Prednisolone Other / unclassified 1 % Topical

Indications